Filter
3283
Filtered Results: 3283
Text search:
drug
promotion
Featured
Recommendations
272
New Publications
967
Language
Document type
No document type
2072
Studies & Reports
503
Guidelines
369
Strategic & Response Plan
124
Manuals
116
Training Material
41
Fact sheets
23
Situation Updates
15
Infographics
14
Resource Platforms
4
Brochures
2
Countries / Regions
India
198
Kenya
110
Global
102
Uganda
93
South Africa
91
Ethiopia
87
Nigeria
75
Liberia
68
Nepal
68
Western and Central Europe
68
Sierra Leone
59
Zambia
59
Tanzania
58
Malawi
54
Ghana
52
Myanmar / Burma
52
Africa
46
Bangladesh
45
Latin America and the Carribbean
44
Namibia
40
Rwanda
37
Cambodia
30
Ukraine
29
Lesotho
29
Asia
29
Zimbabwe
28
Philippines
28
South–East Asia Region
27
Eastern Europe
27
Senegal
21
Botswana
21
Congo, Democratic Republic of
20
Burkina Faso
19
Indonesia
19
Mozambique
17
Syria
15
Haiti
11
Eswatini/ Swaziland
11
Thailand
10
Colombia
10
Russia
10
Cameroon
9
Pakistan
9
Eastern Europe and Central Asia
9
Brazil
8
South Sudan
7
Afghanistan
7
Middle East and North Africa
7
Laos
7
Tajikistan
7
Vietnam
7
Guinea
6
Germany
6
Peru
6
East and Southern Africa
6
West and Central Africa
6
Georgia
6
USA
5
Benin
5
Bolivia
5
Sri Lanka
5
Venezuela
5
Moldova
5
China
4
Sudan
4
Central African Republic
4
Argentina
4
North Macedonia
4
El Salvador
4
Mexico
4
Chile
4
Western Pacific Region
4
Paraguay
4
Albania
4
Iraq
3
Jordan
3
Papua New Guinea
3
Yemen
3
Timor Leste/ East Timor
3
Kyrgyzstan
3
North America
3
Jamaica
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Somalia
2
Lebanon
2
Turkey
2
Hungary
2
Honduras
2
Libya
2
Madagascar
2
Bhutan
2
Poland
2
Palestine
2
Armenia
2
Southern Africa
2
Iran
2
Kazakhstan
2
Uruguay
2
United Kingdom
2
Mali
1
Niger
1
Gambia
1
Ireland
1
Switzerland
1
Serbia
1
Ecuador
1
Guatemala
1
Nicaragua
1
Fiji
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Lithuania
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1421
Clinical Guidelines
224
Public Health
202
Women & Child Health
121
Key Resources
65
Capacity Building
37
Pharmacy & Technologies
23
Toolboxes
HIV
395
Mental Health
339
TB
233
AMR
201
COVID-19
104
Pharmacy
100
NTDs
69
NCDs
69
Caregiver
58
Planetary Health
50
Disability
45
Refugee
44
Global Health Education
38
Rapid Response
35
Ebola
34
Conflict
33
Health Financing Toolbox
17
Cholera
10
Polio
10
Natural Hazards
10
Social Ethics
10
Zika
7
Specific Hazards
6
Health Financing
1
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, development assistance for health (DAH) has grown at an annualized rate of 1.0%. While global development ass...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Strengthening resource tracking and monitorig health expanditure
This report summarizes the World Health Organization’s (WHO) global work on water, sanitation and hygiene (WASH) during 2022. It describes how the Organization continued to deliver its essential WASH programming as elaborated in its 2018–2025 strategy.
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
Unpreparedness of health professionals to address non-communicable diseases (NCD) at peripheral health facilities is a critical health system challenge in Mozambique. To address this weakness and decentralize NCD care, training of the primary care workforce is needed. We describe our experience in t...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
The document "Management of Type 2 Diabetes Mellitus" provides comprehensive guidelines for the diagnosis, prevention, and treatment of type 2 diabetes in adults. It emphasizes the importance of individualized glycemic targets, lifestyle interventions like diet and exercise, and the use of medicatio...
There is increasing interest in understanding the role of air pollution as one of the greatest threats to human health worldwide. Nine of 10 individuals breathe air with polluted compounds that have a great impact on lung tissue. The nature of the relationship is complex, and new or updated data are...
The document "Diabetes and Ramadan: Practical Guidelines 2021," published by Elsevier, provides updated guidance for managing diabetes during Ramadan fasting. Developed by the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance, the guidelines address ke...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
This articel summarises the evidence base underpinning supported self-management for asthma. It provides clinicians with a practical approach to providing supported self-management for asthma and suggests an appropriate strategy for implementing supported self-management.
